Variant report

No.	Distal block	Cell Line	Cell type
1	chr13:110455656..110459242-chr13:110460543..110463426,3	MCF-7	breast:
2	chr13:110457347..110460369-chr13:110462988..110465176,3	K562	blood:
3	chr13:110456902..110459964-chr13:110462988..110465926,5	K562	blood:
4	chr13:110461237..110464119-chr13:110472435..110474206,2	MCF-7	breast:

rSNPs within LD-proxies of this variant (count:20)

rs_ID	r²[population]
rs1414316	0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs1805097	0.87[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs1966662	0.91[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs2117455	0.84[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2289046	0.90[CEU][hapmap]
rs2289047	0.90[CEU][hapmap]
rs35612086	0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs36092351	0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs4547213	0.85[CEU][hapmap]
rs4771648	0.94[CEU][hapmap];0.85[CHB][hapmap];0.85[EUR][1000 genomes]
rs4771649	0.86[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs874016	0.89[CEU][hapmap]
rs892670	0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs9515119	0.89[CEU][hapmap]
rs9521508	0.94[CEU][hapmap]
rs9521510	0.94[CEU][hapmap];0.80[CHB][hapmap];0.85[EUR][1000 genomes]
rs9521512	0.82[CHB][hapmap]
rs9521517	0.86[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs9521518	0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs9521520	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv826788	chr13:110381750-110469062	Flanking Bivalent TSS/Enh Genic enhancers Enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	nsv826789	chr13:110387268-110473524	Weak transcription Genic enhancers Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:9 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:110455800-110469200	Weak transcription	Pancreas	Pancrea
2	chr13:110462200-110464200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr13:110462200-110464200	Enhancers	HSMM	muscle
4	chr13:110462400-110463600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr13:110462800-110463400	Enhancers	NH-A	brain
6	chr13:110463000-110463200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
7	chr13:110463000-110463400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr13:110463000-110463600	Enhancers	Muscle Satellite Cultured Cells	--
9	chr13:110463000-110463600	Enhancers	HSMMtube	muscle

Quick Search: